These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 25147168

  • 1. Off-label uses of alvimopan and methylnaltrexone.
    Rodriguez RW.
    Am J Health Syst Pharm; 2014 Sep 01; 71(17):1450-5. PubMed ID: 25147168
    [Abstract] [Full Text] [Related]

  • 2. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
    Becker G, Blum HE.
    Lancet; 2009 Apr 04; 373(9670):1198-206. PubMed ID: 19217656
    [Abstract] [Full Text] [Related]

  • 3. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats.
    Fukuda H, Suenaga K, Tsuchida D, Mantyh CR, Pappas TN, Hicks GA, Dehaven-Hudkins DL, Takahashi T.
    Brain Res; 2006 Aug 02; 1102(1):63-70. PubMed ID: 16797494
    [Abstract] [Full Text] [Related]

  • 4. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care.
    Candy B, Jones L, Vickerstaff V, Larkin PJ, Stone P.
    Cochrane Database Syst Rev; 2018 Jun 05; 6(6):CD006332. PubMed ID: 29869799
    [Abstract] [Full Text] [Related]

  • 5. Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus.
    Neyens R, Jackson KC.
    J Pain Palliat Care Pharmacother; 2007 Jun 05; 21(2):27-33. PubMed ID: 17844725
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review.
    Mehta N, O'Connell K, Giambrone GP, Baqai A, Diwan S.
    Postgrad Med; 2016 Jun 05; 128(3):282-9. PubMed ID: 26839023
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.
    Ford AC, Brenner DM, Schoenfeld PS.
    Am J Gastroenterol; 2013 Oct 05; 108(10):1566-74; quiz 1575. PubMed ID: 23752879
    [Abstract] [Full Text] [Related]

  • 8. Mu-opioid antagonists for opioid-induced bowel dysfunction.
    McNicol ED, Boyce D, Schumann R, Carr DB.
    Cochrane Database Syst Rev; 2008 Apr 16; (2):CD006332. PubMed ID: 18425947
    [Abstract] [Full Text] [Related]

  • 9. The Efficacy of Peripheral Opioid Antagonists in Opioid-Induced Constipation and Postoperative Ileus: A Systematic Review of the Literature.
    Schwenk ES, Grant AE, Torjman MC, McNulty SE, Baratta JL, Viscusi ER.
    Reg Anesth Pain Med; 2017 Apr 16; 42(6):767-777. PubMed ID: 29016552
    [Abstract] [Full Text] [Related]

  • 10. Methylnaltrexone: MNTX.
    Drugs R D; 2006 Apr 16; 7(6):374-8. PubMed ID: 17073520
    [Abstract] [Full Text] [Related]

  • 11. Evidence Based Review of Pharmacotherapy for Opioid-Induced Constipation in Noncancer Pain.
    Murphy JA, Sheridan EA.
    Ann Pharmacother; 2018 Apr 16; 52(4):370-379. PubMed ID: 29092627
    [Abstract] [Full Text] [Related]

  • 12. Peripherally Acting μ-Opioid Receptor Antagonists in the Management of Postoperative Ileus: a Clinical Review.
    Chamie K, Golla V, Lenis AT, Lec PM, Rahman S, Viscusi ER.
    J Gastrointest Surg; 2021 Jan 16; 25(1):293-302. PubMed ID: 32779081
    [Abstract] [Full Text] [Related]

  • 13. New drugs: methylnaltrexone bromide, alvimopan, and rilonacept.
    Hussar DA.
    J Am Pharm Assoc (2003); 2008 Jan 16; 48(5):688-91. PubMed ID: 18826910
    [No Abstract] [Full Text] [Related]

  • 14. Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.
    Mori M, Ji Y, Kumar S, Ashikaga T, Ades S.
    Int J Clin Oncol; 2017 Apr 16; 22(2):397-404. PubMed ID: 27628064
    [Abstract] [Full Text] [Related]

  • 15. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.
    Slatkin N, Thomas J, Lipman AG, Wilson G, Boatwright ML, Wellman C, Zhukovsky DS, Stephenson R, Portenoy R, Stambler N, Israel R.
    J Support Oncol; 2009 Apr 16; 7(1):39-46. PubMed ID: 19278178
    [Abstract] [Full Text] [Related]

  • 16. Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.
    Rauck RL.
    Drugs; 2013 Aug 16; 73(12):1297-306. PubMed ID: 23881667
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Subcutaneous methylnaltrexone to restore postoperative bowel function in a long-term opiate user.
    Ladanyi A, Temkin SM, Moss J.
    Int J Gynecol Cancer; 2010 Feb 16; 20(2):308-10. PubMed ID: 20134275
    [Abstract] [Full Text] [Related]

  • 19. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH, Cross K, Winston JL, Thomas J, Wang W, Su C, Israel RJ.
    J Pain Symptom Manage; 2009 Nov 16; 38(5):683-90. PubMed ID: 19713070
    [Abstract] [Full Text] [Related]

  • 20. Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study.
    Lipman AG, Karver S, Cooney GA, Stambler N, Israel RJ.
    J Pain Palliat Care Pharmacother; 2011 Nov 16; 25(2):136-45. PubMed ID: 21657861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.